This study was supported by Ironwood Pharmaceuticals and Forest Research Institute, the developers of linaclotide. Dr. Lembo reported receiving consulting and/or honorarium and other fees from both companies, as well as grant funding from Novartis, and serving as a consultant for numerous other companies. The other authors reported being employed by, and owning stock or stock options in, either Ironwood Pharmaceuticals or Forest Research Institute.
FROM THE NEW ENGLAND JOURNAL OF MEDICINE